Mucosolvan



Indications and Reactions:

Role Indications Reactions
Primary
Antibiotic Therapy 50.0%
Increased Upper Airway Secretion 50.0%
Heart Rate Increased 100.0%
Secondary
Hypertension 15.6%
Product Used For Unknown Indication 15.3%
Drug Use For Unknown Indication 10.8%
Psoas Abscess 7.9%
Pain 7.5%
Pneumonia 6.3%
Pyrexia 3.9%
Supplementation Therapy 3.6%
Thrombosis Prophylaxis 3.6%
Cough 3.2%
Rheumatoid Arthritis 3.0%
Upper Respiratory Tract Inflammation 3.0%
Asthma 2.6%
Hyperglycaemia 2.4%
Idiopathic Pulmonary Fibrosis 2.2%
Polyuria 2.1%
Ill-defined Disorder 1.9%
Fluid Replacement 1.8%
Restlessness 1.8%
Diarrhoea 1.7%
Stevens-johnson Syndrome 21.1%
Toxic Epidermal Necrolysis 7.0%
Urticaria 7.0%
Hepatic Function Abnormal 5.6%
Liver Disorder 5.6%
Pneumonia 5.6%
Respiratory Failure 5.6%
Fear 4.2%
Pneumonia Aspiration 4.2%
Pyrexia 4.2%
Rash 4.2%
Compression Fracture 2.8%
Gastric Ulcer Haemorrhage 2.8%
Intentional Self-injury 2.8%
Jaundice 2.8%
Lymphangiosis Carcinomatosa 2.8%
Myocardial Infarction 2.8%
Pallor 2.8%
Restlessness 2.8%
Tracheal Stenosis 2.8%
Concomitant
Product Used For Unknown Indication 14.8%
Prophylaxis 11.6%
Asthma 9.0%
Rheumatoid Arthritis 8.5%
Hypertension 7.5%
Drug Use For Unknown Indication 7.1%
Pneumonia 5.6%
Bronchitis 5.4%
Constipation 3.6%
Gastritis 3.2%
Cough 3.1%
Insomnia 2.9%
Influenza 2.4%
Diabetes Mellitus 2.4%
Cardiac Failure 2.3%
Emphysema 2.3%
Nasopharyngitis 2.1%
Osteoporosis 2.0%
Bronchitis Chronic 2.0%
Chronic Obstructive Pulmonary Disease 2.0%
Interstitial Lung Disease 12.4%
Pneumonia 12.0%
Pyrexia 10.4%
Vomiting 6.7%
Rash 5.7%
Death 5.5%
White Blood Cell Count Decreased 4.9%
Rhabdomyolysis 4.7%
Respiratory Failure 4.1%
Hepatic Function Abnormal 3.7%
Asthma 3.5%
Sepsis 3.5%
White Blood Cell Count Increased 3.5%
Renal Failure Acute 3.3%
Renal Impairment 3.3%
Abnormal Behaviour 2.6%
Pleural Effusion 2.6%
Somnolence 2.6%
Tremor 2.6%
Platelet Count Decreased 2.4%